
Evening Symposium 5
Latest Evidence on Methotrexate and JAK Inhibitors Objectives: This session will discuss the combination therapy of JAK inhibitors with MTX and JAK inhibitors monotherapy. Agenda – Saturday 31 October Chairperson: Seong-Ho Kim 1730-1825 Latest Evidence on Methotrexate and JAK Inhibitors Yuko Kaneko







